Beam Therapeutics Inc. Related Party Transaction, Expenses from Transactions with Related Party
Beam Therapeutics Inc. (BEAM) reported Related Party Transaction, Expenses from Transactions with Related Party of $5.50 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-15.
Discontinued › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2021-03-15
- Beam Therapeutics Inc. related party transaction, expenses from transactions with related party for the quarter ending 2020-12-31 was $500.00K.
- Beam Therapeutics Inc. related party transaction, expenses from transactions with related party for fiscal 2020 was $5.50M.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 1 month | Related Party Transaction, Expenses from Transactions with Related Party 3 month | Related Party Transaction, Expenses from Transactions with Related Party 9 month | Related Party Transaction, Expenses from Transactions with Related Party 12 month |
|---|---|---|---|---|
| 2020-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $5.50M 10-K · filed 2021-03-15 | ||
| 2020-10-31 | $100.00K 10-K · filed 2021-03-15 | |||
| 2020-09-30 | $5.00M 10-Q · filed 2020-11-10 | $5.00M 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |